INOVIO PHARMACEUTICALS, INC. Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2023.
  • Inovio Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $424K, a 40% decline year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Depreciation for 2023 was $2.62M, a 28.3% decline from 2022.
  • Inovio Pharmaceuticals, Inc. annual Depreciation for 2022 was $3.66M, a 20.3% increase from 2021.
  • Inovio Pharmaceuticals, Inc. annual Depreciation for 2021 was $3.04M, a 0.04% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.62M -$1.04M -28.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $3.66M +$617K +20.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $3.04M +$1.1K +0.04% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $3.04M -$559K -15.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $3.6M -$149K -3.97% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $3.75M +$1.9M +103% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $1.85M +$142K +8.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $1.71M +$660K +63% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $1.05M +$422K +67.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $627K +$298K +90.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $329K +$155K +89.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $174K +$31.6K +22.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $142K -$52.4K -26.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $195K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.